Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Information for patients and caregivers on how to manage adverse events from immune checkpoint inhibitors
Rates of participation by Blacks would need to more than triple to match their share of the population living with cancer.
Combining a personalized cancer vaccine and a checkpoint inhibitor generated tumor-specific immune responses in a majority of patients
A novel liquid biopsy method can detect kidney cancers with high accuracy, including small, localized tumors which are often curable.
A meme making the rounds claims that the vegetable can cure cancer—despite no evidence.
Sociodemographic factors may play a role in whether people receive immunotherapy.
A recent survey found a low level of consistent sunscreen use and insufficient concern about skin cancer.
Cholesterol-lowering medications were associated with at least a 40% reduction in mortality.
These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.
By recording such details, clinicians can aid in improving LGBTQIA+ health disparities, argues a researcher.
Researchers identify a series of molecular abnormalities associated with greater risk of myeloma progression
Researchers analyzed how a combination of cancer treatments and inherited mutations in DNA-repair genes predicted new cancers.
This finding means those considered at low risk for colon cancer might be able to safely delay a subsequent scan.
Dexamethasone reduced mortality by up to a third among severely ill patients who needed supplemental oxygen or ventilators.
Lurbinectedin shrank tumors in a third of people with this less common type of lung cancer.
This new test could “play an important role” in screening people who are at risk for developing hepatocellular carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.